0000904454-14-000115.txt : 20140129 0000904454-14-000115.hdr.sgml : 20140129 20140129205517 ACCESSION NUMBER: 0000904454-14-000115 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140129 FILED AS OF DATE: 20140129 DATE AS OF CHANGE: 20140129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL ST. BUILDING 1, SUITE 120 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 480 ARSENAL ST. BUILDING 1, SUITE 120 CITY: WATERTOWN STATE: MA ZIP: 02472 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOVEY BRIAN H CENTRAL INDEX KEY: 0001207786 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 14558442 MAIL ADDRESS: STREET 1: ONE PALMER SQUARE CITY: PRINCETON STATE: NJ ZIP: 08542 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2014-01-29 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001207786 DOVEY BRIAN H C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE PRINCETON NJ 08542 0 0 1 0 Series B Preferred Stock Common Stock 476464 I By Domain Partners VIII, L.P. Series C Preferred Stock Common Stock 1276243 I By Domain Partners VIII, L.P. Warrant 7.00 2014-01-29 2018-06-26 Series C Preferred Stock 21041 I By Domain Partners VIII, L.P. Series B Preferred Stock Common Stock 3535 I By DP VIII Associates, L.P. Series C Preferred Stock Common Stock 9469 I By DP VIII Associates, L.P. Warrant 7.00 2014-01-29 2018-06-26 Series C Preferred Stock 156 I By DP VIII Associates, L.P. All outstanding Preferred Stock will automatically convert into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The Preferred Stock has no expiration date. The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (5)(b)(iv) of Form 3, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her. /s/ Kathleen K. Schoemaker, Attorney-in-Fact 2014-01-29